Dr. Carolyn Britten on Next Steps in Immunotherapy
September 15th 2015Carolyn D. Britten, MD, chief, Division of Hematology Oncology, associate director, Clinical Investigations, at the Hollings Cancer Center, Medical University of South Carolina, discusses questions that remain in immunotherapy.
Read More